Gel Aqua Women's ASICS Diva White 7 Tennis Resolution Shoe Blue Splash qYHY5TFx at uber-traffic.com

JACC: Basic to Translational Science(2018)

引用 43|浏览1
暂无评分
摘要
The U.S. Food and Drug Administration recently marked 10 years since first updating the labeling for warfarin (often referred to as the “poster child” of pharmacogenomics) to include information regarding the potential impact of CYP2C9 and VKORC1 genetic variation on warfarin dosing requirements and risks. Herein, we opine on the experience updating the warfarin labeling, highlighting more generally the enabling factors and challenges encountered when considering incorporation of pharmacogenomic information into the prescribing recommendations for already approved drugs. We also provide a historical perspective of implemented changes in regulatory policies related to personalized medicine.
更多
查看译文
关键词
drug labeling,pharmacogenomics,precision medicine,regulatory perspective,warfarin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要